Literature DB >> 23116652

2-Hydroxyestradiol enhances binge onset in female rats and reduces prefrontal cortical dopamine in male rats.

R K Babbs1, E L Unger, R L W Corwin.   

Abstract

Women are more likely to suffer from a bingeing-related eating disorder, which is surprising, since estradiol reduces meal size and is associated with reduced binge frequency. This apparent contradiction may involve the estradiol metabolite, 2-hydroxyestradiol. We previously reported that female rats had faster escalations in shortening intake during the development of bingeing than did males, but acute administration of 2-hydroxyestradiol increased the intake of vegetable shortening to a greater extent in male rats once bingeing was established. Here, we report two separate studies that follow up these previous findings. In the first, we hypothesized that chronic exposure to 2-hydroxyestradiol would promote escalation of bingeing during binge development in ovariectomized female rats. In the second, we hypothesized that acute exposure to 2-hydroxyestradiol would enhance dopamine signaling in the prefrontal cortex after bingeing was established in male rats. In study 1, non-food-deprived female rats were separated into 3 groups: ovariectomized (OVX) with chronic 2-hydroxyestradiol supplementation (E), OVX with vehicle supplementation (O), and intact with vehicle (I). Each group was given access to an optional source of dietary fat (shortening) on Mon, Wed, and Fri for 4 weeks. 2-hydroxyestradiol supplementation prevented OVX-induced weight gain and enhanced escalation of shortening intake over the four-week period (ps<0.05). Additionally, in week 4, rats in the E group ate significantly more shortening than I controls, less chow than either the O or I group, and had a higher shortening to chow ratio than O or I (ps<0.05). Study 2 indicated that acute injection of 2-hydroxyestradiol abolished shortening-evoked dopamine efflux in the prefrontal cortex of bingeing male rats (p<0.05). Together, these studies indicate that 2-hydroxyestradiol can exacerbate bingeing as it develops and can suppress dopamine signaling in the prefrontal cortex once bingeing is established.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116652      PMCID: PMC3586335          DOI: 10.1016/j.yhbeh.2012.10.010

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  42 in total

1.  Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain.

Authors:  V Kaasinen; K Någren; J Hietala; L Farde; J O Rinne
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

2.  2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats.

Authors:  S P Tofovic; R K Dubey; E K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

3.  2-Hydroxyestradiol interaction with dopamine receptor binding in rat anterior pituitary.

Authors:  J M Schaeffer; A J Hsueh
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

4.  Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver.

Authors:  P Ball; R Knuppen; M Haupt; H Breuer
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

Review 5.  Body size and energy metabolism.

Authors:  A A Heusner
Journal:  Annu Rev Nutr       Date:  1985       Impact factor: 11.848

6.  The possible role of 2-hydroxyestradiol in the development of estrogen-induced striatal dopamine receptor hypersensitivity.

Authors:  J K Clopton; J H Gordon
Journal:  Brain Res       Date:  1985-04-29       Impact factor: 3.252

Review 7.  Reward, dopamine and the control of food intake: implications for obesity.

Authors:  Nora D Volkow; Gene-Jack Wang; Ruben D Baler
Journal:  Trends Cogn Sci       Date:  2010-11-24       Impact factor: 20.229

Review 8.  Dopamine and binge eating behaviors.

Authors:  Nicholas T Bello; Andras Hajnal
Journal:  Pharmacol Biochem Behav       Date:  2010-04-24       Impact factor: 3.533

9.  Medial prefrontal cortex activity associated with symptom provocation in eating disorders.

Authors:  Rudolf Uher; Tara Murphy; Michael J Brammer; Tim Dalgleish; Mary L Phillips; Virginia W Ng; Christopher M Andrew; Steven C R Williams; Iain C Campbell; Janet Treasure
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

10.  2-hydroxyestradiol is a prodrug of 2-methoxyestradiol.

Authors:  Lefteris C Zacharia; Claude A Piché; Robert M Fielding; Kathleen M Holland; S Dean Allison; Raghvendra K Dubey; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2004-02-10       Impact factor: 4.030

View more
  8 in total

Review 1.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

2.  Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.

Authors:  L R Goldberg; S L Kirkpatrick; N Yazdani; K P Luttik; O A Lacki; R K Babbs; D F Jenkins; W E Johnson; C D Bryant
Journal:  Genes Brain Behav       Date:  2017-07-06       Impact factor: 3.449

3.  Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating.

Authors:  Stacey L Kirkpatrick; Lisa R Goldberg; Neema Yazdani; R Keith Babbs; Jiayi Wu; Eric R Reed; David F Jenkins; Amanda F Bolgioni; Kelsey I Landaverde; Kimberly P Luttik; Karen S Mitchell; Vivek Kumar; W Evan Johnson; Megan K Mulligan; Pietro Cottone; Camron D Bryant
Journal:  Biol Psychiatry       Date:  2016-10-25       Impact factor: 13.382

4.  Removal of high-fat diet after chronic exposure drives binge behavior and dopaminergic dysregulation in female mice.

Authors:  Jesse L Carlin; Sarah E McKee; Tiffany Hill-Smith; Nicola M Grissom; Robert George; Irwin Lucki; Teresa M Reyes
Journal:  Neuroscience       Date:  2016-04-08       Impact factor: 3.590

5.  The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats.

Authors:  Antonio Ferragud; Adam D Howell; Catherine F Moore; Tina L Ta; Marius C Hoener; Valentina Sabino; Pietro Cottone
Journal:  Neuropsychopharmacology       Date:  2016-10-06       Impact factor: 7.853

Review 6.  Food Addiction and Binge Eating: Lessons Learned from Animal Models.

Authors:  Marta G Novelle; Carlos Diéguez
Journal:  Nutrients       Date:  2018-01-11       Impact factor: 5.717

7.  Intra-accumbens Raclopride Administration Prevents Behavioral Changes Induced by Intermittent Access to Sucrose Solution.

Authors:  Josué O Suárez-Ortiz; Felipe Cortés-Salazar; Ariadna L Malagón-Carrillo; Verónica E López-Alonso; Juan M Mancilla-Díaz; Juan G Tejas-Juárez; Rodrigo E Escartín-Pérez
Journal:  Front Neurosci       Date:  2018-02-21       Impact factor: 4.677

8.  Inflammation in VTA Caused by HFD Induces Activation of Dopaminergic Neurons Accompanied by Binge-like Eating.

Authors:  Runan Sun; Mariko Sugiyama; Sixian Wang; Mitsuhiro Kuno; Tomoyuki Sasaki; Tomonori Hirose; Takashi Miyata; Tomoko Kobayashi; Taku Tsunekawa; Takeshi Onoue; Yoshinori Yasuda; Hiroshi Takagi; Daisuke Hagiwara; Shintaro Iwama; Hidetaka Suga; Hiroshi Arima
Journal:  Nutrients       Date:  2022-09-16       Impact factor: 6.706

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.